ASH 47th (2005)

Drupal spam blocked by CleanTalk.
Title Content type
Acquired Pure Red Cell Aplasia Associated with Alemtuzumab, Mycophenolate, and Daclizumab Immunosuppression after Pancreas Transplant. (click for details)
Antifungal Treatment with Caspofungin: A Single Centre Experience. (click for details)
NNDR Salvage Biochemotherapy Regimens for Therapy-Refractory Leukemia and Lymphoma Patients: A Report from the Parker Hughes Cancer Center. (click for details)
Combined Therapy with Alemtuzumab and Pentostatin Is Feasible and Effective in T- Lymphoprolifertive Disorders. (click for details)
Itraconazole for Antifungal Prophylaxis in Neutropenic Patients: An Update of a Meta-Analysis with Now 3846 Patients. (click for details)
Preliminary Results of a Prospective Randomized Study Comparing First Line Conventional Therapy Versus High Dose Therapy with Autologous CD34+ Purified Progenitor Cell Support in B CLL Patients with B and C Binet Stages: The GOELAMS LLC98 Study. (click for details)
Successful Allogeneic HSCT in a Patient with Chronic Granulomatous Disease and McLeod Phenotype after Sensitization to Kx- and K- Antigens. (click for details)
Antifungal Prophylaxis with Oral and Intravenous Itraconazole in Pediatric Stem Cell Tansplantation: A Retrospective Comparison with Fluconazole and Amphotericin B-Preparations in 116 Children. (click for details)
Posaconazole vs Standard Azole (FLU/ITRA) Therapy for Prophylaxis of Invasive Fungal Infections (IFIs) among High-Risk Neutropenic Patients: Results of a Randomized, Multicenter Trial. (click for details)
Effects of Mycotoxins on Mononuclear Cells (MNCs) in Normal Blood, T-Cell Leukemia and Lymphoma Cell Lines. (click for details)

Pages

Subscribe to ASH 47th (2005)